Skip to main content
. 2021 Dec 6;24(3):264–276. doi: 10.1111/codi.15997

TABLE 3.

Clinical staging and pathological data

No AL AL 95% CI Total P
Tumour distance from the AV (cm) Median (IQR) 9.0 (6.0–12.0) 8.0 (5.0–11.0) 9.0 (6.0–12.0) 0.042
Cancer location (anatomical subdivision) Upper rectum 1482 (91.5) 137 (8.5) 3.7–17.6 1619 (100) 0.004
Middle rectum 2153 (89.1) 263 (10.9) 8.9–11.6 2416 (100)
Lower rectum 984 (87.8) 137 (12.2) 13.8–22.1 1121 (100)
(Missing) 227 (93.8) 15 (6.2) 242 (100)
cT cT0–1–2 1146 (92.2) 97 (7.8) 1243 0.043
cT3–4 2161 (90.2) 236 (9.8) 2397
(Missing) 1539 (87.5) 219 (12.5) 1758
cN cN0 1880 (92.2) 159 (7.8) 2039 0.166
cN1 499 (89.9) 56 (10.1) 555
cN2 154 (93.3) 11 (6.7) 165
(Missing) 2313 (87.6) 326 (12.4) 2639
cM cM0 3299 (91.1) 321 (8.9) 3620 0.750
cM1 136 (91.9) 12 (8.1) 148
(y)pT stage In situ 85 (94.4) 5 (5.6) 9.7–12.2 90 (100) <0.001
0 388 (91.5) 36 (8.5) 10.4–14.3 424 (100)
1 560 (93.6) 38 (6.4) 3.5–10 598 (100)
2 1190 (90.8) 121 (9.2) 6–11.6 1311 (100)
3 2210 (88.5) 286 (11.5) 4.5–8.6 2496 (100)
4 302 (85.6) 51 (14.4) 7.7–10.9 353 (100)
(Missing) 111 (88.1) 15 (11.9) 126 (100)
(y)pN stage 0 3100 (91.0) 307 (9.0) 11–18.6 3407 (100) <0.001
1 1047 (88.4) 138 (11.6) 1.8–12.5 1185 (100)
2 612 (86.2) 98 (13.8) 6.8–18.9 710 (100)
(Missing) 87 (90.6) 9 (9.4) 96 (100)
pM stage 0 4210 (89.9) 475 (10.1) 9.9–13.6 4685 (100) 0.371
1 470 (88.5) 61 (11.5) 11.4–16.6 531 (100)
(Missing) 166 (91.2) 16 (8.8) 182 (100)
R grade 0 4279 (90.5) 449 (9.5) 9.3–11 4728 (100) 0.708
1 82 (89.1) 10 (10.9) 8.9–14.5 92 (100)
2 143 (88.8) 18 (11.2) 5.1–13.9 161 (100)
(Missing) 342 (82.0) 75 (18.0) 417 (100)
Mandard TRG No. Median (IQR) 3.0 (2.0–4.0) 3.0 (2.0–4.0) 3.0 (2.0–4.0) 0.379
(Missing) 3355 (89.8) 382 (10.2) 3737 (100)

Bold indicated significance value (P < 0.05).

Abbreviations: (y)pN, pathological N stage according to the 8th edition of the TNM classification after neoadjuvant treatment (Y) when administered; (y)pT, pathological T stage according to the 8th edition of the TNM classification after neoadjuvant treatment (Y) when administered; AL, anastomotic leak; AV, anal verge; IQR, interquartile range; pM, pathological M stage according to the 8th edition of the TNM classification; R grade, residual tumour classification (R0 corresponds to resection for cure or complete remission; R1 to microscopic residual tumour and R2 to macroscopic residual tumour).